s'authentifier
version française rss feed
A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism.
Celestino-Soper P. B. S., Violante S., Crawford E. L., Luo R., Lionel A. C., Delaby E., Cai G., Sadikovic B., Lee K., Lo C. et al
Proceedings- National Academy of Sciences Usa 109, 21 (2012) 7974-81 - http://www.hal.inserm.fr/inserm-00696112
 (22566635) 
A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism.
Patrícia Celestino-Soper1, Sara Violante2, 3, Emily Crawford4, Rui Luo5, Anath Lionel6, Elsa Delaby7, Guiqing Cai8, Bekim Sadikovic1, Kwanghyuk Lee1, Charlene Lo1, Kun Gao5, Richard Person1, Timothy Moss1, Jennifer German1, Ni Huang9, Marwan Shinawi1, 10, Diane Treadwell-Deering10, 11, Peter Szatmari12, Wendy Roberts13, Bridget Fernandez14, Richard Schroer15, Roger Stevenson15, Joseph Buxbaum8, Catalina Betancur7, Stephen Scherer6, 13, Stephan Sanders16, Daniel Geschwind5, James Sutcliffe4, Matthew Hurles9, Ronald Wanders3, Chad Shaw1, Suzanne Leal1, Edwin Cook17, Robin Goin-Kochel1, 10, 18, Frédéric Vaz3, Arthur Beaudet () 1, 10, 18
1 :  Department of Molecular and Human Genetics
Baylor College of Medicine
Houston, TX 77030
États-Unis
2 :  Metabolism and Genetics Group
Research Institute for Medicines and Pharmaceutical Sciences – Universidade de Lisboa
iMed.UL, Faculdade de Farmácia, 1649-003 Lisbon
Portugal
3 :  Laboratory Genetic Metabolic Disease
Academic Medical Center – University of Amsterdam
Departments of Clinical Chemistry and Pediatrics, 1105 AZ, Amsterdam
Pays-Bas
4 :  Department of Molecular Physiology and Biophysics
Centers for Human Genetics Research and Molecular Neuroscience – Vanderbilt University
Nashville, Tennessee 37232
États-Unis
5 :  Department of Human Genetics
University of California, Los Angeles – Semel Institute
David Geffen School of Medicine, CA 90095
États-Unis
6 :  The Centre for Applied Genomics and Program in Genetics and Genomic Biology
The Hospital for Sick Children
Toronto, Ontario, M5G 1L7
Canada
7 :  Physiopathologie des Maladies du Système Nerveux Central
INSERM : U952 – Université Pierre et Marie Curie [UPMC] - Paris VI – CNRS : UMR7224
Bât. B, 4ème étage, case courrier 37 9 quai Saint Bernard 75252 Paris Cedex 05
France
8 :  Seaver Autism Research Center
Mount Sinai School of Medicine
New York
États-Unis
9 :  Department of Neurology
Johns Hopkins University
733 North Broadway Baltimore, MD 21205-2196
États-Unis
10 :  Texas Children's Hospital
Texas Children's Hospital
Houston, TX 77030
États-Unis
11 :  Department of psychiatry
Baylor College of Medicine
Houston, TX 77030
États-Unis
12 :  Department of Psychiatry and Behavioural Neurosciences
McMaster University
The Offord Centre for Child Studies, McMaster Children's Hospital, Hamilton, ON, L8S 4L8
Canada
13 :  Autism Research Unit
The Hospital for Sick Children and Bloorview Kids Rehabilitation – University of Toronto
Toronto, Ontario, M5G 1Z8
Canada
14 :  Disciplines of Genetics and Medicine
Memorial University of Newfoundland
St. John's Newfoundland
Canada
15 :  Greenwood Genetic Center
Greenwood Genetic Center
Greenwood, SC 29646
États-Unis
16 :  Departments of Psychiatry and Genetics
Yale University School of Medicine
Program on Neurogenetics, Child Study Center , New Haven, CT 06520
États-Unis
17 :  Department of Psychiatry
Institute for Juvenile Research – University of Illinois at Chicago
Chicago, Illinois
États-Unis
18 :  Department of pediatrics
Baylor College of Medicine
Houston, TX 77030
États-Unis
We recently reported a deletion of exon 2 of the trimethyllysine hydroxylase epsilon (TMLHE) gene in a proband with autism. TMLHE maps to the X chromosome and encodes the first enzyme in carnitine biosynthesis, 6-N-trimethyllysine dioxygenase. Deletion of exon 2 of TMLHE causes enzyme deficiency, resulting in increased substrate concentration (6-N-trimethyllysine) and decreased product levels (3-hydroxy-6-N-trimethyllysine and γ-butyrobetaine) in plasma and urine. TMLHE deficiency is common in control males (24 in 8,787 or 1 in 366) and was not significantly increased in frequency in probands from simplex autism families (9 in 2,904 or 1 in 323). However, it was 2.82-fold more frequent in probands from male-male multiplex autism families compared with controls (7 in 909 or 1 in 130; P = 0.023). Additionally, six of seven autistic male siblings of probands in male-male multiplex families had the deletion, suggesting that TMLHE deficiency is a risk factor for autism (metaanalysis Z-score = 2.90 and P = 0.0037), although with low penetrance (2-4%). These data suggest that dysregulation of carnitine metabolism may be important in nondysmorphic autism; that abnormalities of carnitine intake, loss, transport, or synthesis may be important in a larger fraction of nondysmorphic autism cases; and that the carnitine pathway may provide a novel target for therapy or prevention of autism.
Sciences du Vivant/Génétique
Anglais
0027-8424

Articles dans des revues avec comité de lecture
10.1073/pnas.1120210109
Proceedings- National Academy of Sciences Usa
internationale
22/05/2012
07/05/2012
109
21
7974-81

Autistic Disorder – Carnitine – Chromosomes – Human – X – Cognition – Exons – Gene Deletion – Genes – X-Linked – Humans – Male – Metabolism – Inborn Errors – Mixed Function Oxygenases – Penetrance – Risk Factors – Siblings
The AGRE is a program of Autism Speaks and is supported, in part, by Grant 1U24MH081810 from the National Institute of Mental Health (to Clara M. Lajonchere). Part of this work was supported by Grant SFARI 124827 from the Simons Foundation (to the investigators of the SSC Genetic Consortium) and Grant HD-37283 (to A.L.B) and Grant P30HD-0240640 from the National Institutes of Health. Part of this work was financially supported by the Fundação para a Ciência e Tecnologia, Lisbon, Portugal, by Grant SFRH/BD/38074/2007 (to. S.V.). Part of this work was supported by National Institutes of Health Grants R01 MH061009 and R01 NS049261 (to J.S.S.). Funding for part of this work was provided by the Wellcome Trust under Award 076113 and by Grant 077014/Z/05/Z. Funding for the Paris Autism Research International Sibpair study was provided, in part, by the Institut National de la Santé et de la Recherche Médicale, Fondation de France, Fondation Orange, Fondation pour la Recherche Médicale, Assistance Publique- Hôpitaux de Paris, and the Swedish Science Council.
Liste des fichiers attachés à ce document : 
PDF
PNAS-2012-Celestino-Soper-1120210109.pdf(1.2 MB)
ANNEX
Celestino-Soper_Supporting_Information_PNAS_2012.pdf(523.8 KB)

tous les articles de la base du CCSd...